Awan N A, Miller R R, Maxwell K, Mason D T
Clin Pharmacol Ther. 1977 Jul;22(1):79-84. doi: 10.1002/cpt197722179.
The effects of oral prazosin on the peripheral circulation were evaluated in 10 subjects, including 7 patients with chronic congestive failure due to coronary heart disease. To achieve this purpose the actions of 30 to 50 micrograms/kg body weight prazosin were assessed on both the forearm arteriolar and venous beds simultaneously with the use of the limb plethysmographic technique. Prazosin produced marked decline of forearm venous tone (FVT) from 44.5 +/- 12.3 to 14.3 +/- 3.1 mm Hg/ml (p less than 0.01) concomitant with marked decrease in forearm vascular resistance (FVR) from 70.2 +/- 11.4 to 48.4 +/- 4.9 mm Hg/ml/100 gm/min (p less than 0.05) which persisted for at least 60 mins without change in heart rate. These findings, demonstrating that prazosin induces systemic venodilation and peripheral arteriolodilation, indicate potential benefits of the oral drug for relief of pulmonary congestion and elevations of cardiac output in patients with chronic congestive heart failure.
在10名受试者中评估了口服哌唑嗪对周围循环的影响,其中包括7名因冠心病导致慢性充血性心力衰竭的患者。为实现这一目的,采用肢体体积描记技术,同时评估了30至50微克/千克体重哌唑嗪对前臂小动脉和静脉床的作用。哌唑嗪使前臂静脉张力(FVT)从44.5±12.3显著降至14.3±3.1毫米汞柱/毫升(p<0.01),同时前臂血管阻力(FVR)从70.2±11.4显著降至48.4±4.9毫米汞柱/毫升/100克/分钟(p<0.05),且至少持续60分钟,心率无变化。这些结果表明哌唑嗪可引起全身静脉扩张和外周小动脉扩张,提示口服该药对缓解慢性充血性心力衰竭患者的肺充血和提高心输出量可能有益。